Tim Chiang, BTIG Specialty Pharmaceuticals and Biotechnology Analyst, discusses Valeant on CNBC.
BTIG’s Tim Chiang Appears on CNBC to Discuss the Latest Valeant News

Notification bar text goes here

Tim Chiang, BTIG Specialty Pharmaceuticals and Biotechnology Analyst, discusses Valeant on CNBC.